On October 6, 2025, Microbot Medical Inc. reported the exercise of 1,324,488 preferred investment options for common stock at $2.10 per share and issued new options to investors, marking the last exercise under a previous agreement. This event is significant as it impacts the company's capital structure and investor relations.